Lipids and Lipid Derivatives
Selleck Chemical LLC Alantolactone
Alantolactone a naturally occurring eudesmane-type sesquiterpene lactone (SL) could induce activin/SMAD3 signaling and disrupt Cripto-1/activin receptor type II A interaction
Abcam Idebenone, antio x idant and neuroprotective agent, 10MG
MW 338.4 Da, Purity >98%. Potent antioxidant and neuroprotective agent. Coenzyme Q analogue. Active in vivo..
The product is subject to the following: Abcam Restricted Use Statement
C(O)=O | 1g | 205389269](https://assets.fishersci.com/TFS-Assets/CCG/product-images/NC1966890.PNG-250.jpg)
eMolecules (S)-N-Boc-allylglycine | Combi-Blocks | 90600-20-7 | | 215.249 | C10H17NO4 | 96.000 | CC(C)(C)OC(=O)N[C@@H](CC=C)C(O)=O | 1g | 205389269
(S)-N-Boc-allylglycine | Combi-Blocks | 90600-20-7 | | 215.249 | C10H17NO4 | 96.000 | CC(C)(C)OC(=O)N[C@@H](CC=C)C(O)=O | 1g | 205389269
Enzo Life Sciences 20-Hydroxyecdysone (10mg). CAS: 5289-74-7
Most widely occurring ecdysteroid in both plant and animal species. Controls cell death during metamorphosis of Drosophila melanogaster. Alternative name: beta-Ecdysone, 2beta,3beta,14alpha,20R,22R,25-Hexahydroxy-5beta-cholest-7-en-6-one, Ecdysterone. Purity: ≥95% HPLC. Solubility: Soluble in water, 100% ethanol, methanol, DMSO and acetic acid. Long Term Storage: -20°C.
Enzo Life Sciences 1,2-Dilauroyl-sn-glycero-3-phosphocholine (250mg). CAS: 18194-25-7
Alternative name: DLPC. Purity: ≥99% (TLC). Appearance: White to off-white solid. Solubility: 20mg/ml soluble in chloroform:methanol:acetic acid:water (100:30:10:2.5); slightly soluble in methanol. Long Term Storage: -20°C.
Apexbio Technology LLC Monomethyl auristatin E 474645-27-7 50mg
Monomethyl auristatin E (MMAE) is a highly potent antimitotic compound that exerts cytotoxic effects by inhibiting tubulin polymerization Microtubules play essential roles in various cellular processes including intracellular transport cell migration and mitotic chromosome segregation MMAE interrupts this process leading to cell cycle arrest and apoptosis MMAE is commonly utilized in preclinical and clinical studies as the cytotoxic payload in antibody-drug conjugates (ADCs) targeting tumor-specific antigens to selectively deliver cytotoxicity to cancer cells In vitro cell studies and in vivo tumor xenograft models show that antibody conjugation enables specific targeting resulting in reduced off-target toxicity and improved therapeutic index compared to unconjugated cytotoxic agents